カテゴリー： QYResearch, 世界

世界のポリペプチド薬市場

◆英語タイトル：Global Polypeptide Drug Market Professional Survey Report 2019
◆商品コード：DATA909X13371
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：110
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、ポリペプチド薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、注射、経鼻投与、肺投与、経口投与、経皮投与に、用途別には、免疫調節薬（アレルギー感染＆免疫）、消化器系薬（胃腸型）、骨および結合組織型（甲状腺ホルモン薬）、婦人科または産科薬、腫瘍薬、尿系薬、代謝薬（インスリンおよびその他の血糖降下薬）にセグメント区分し、ポリペプチド薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・ポリペプチド薬の世界市場概要
・ポリペプチド薬の製造コスト構成分析
・ポリペプチド薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・ポリペプチド薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・ポリペプチド薬のセグメント分析（種類別）
（注射、経鼻投与、肺投与、経口投与、経皮投与）
・ポリペプチド薬のセグメント分析（用途別）
（免疫調節薬（アレルギー感染＆免疫）、消化器系薬（胃腸型）、骨および結合組織型（甲状腺ホルモン薬）、婦人科または産科薬、腫瘍薬、尿系薬、代謝薬（インスリンおよびその他の血糖降下薬））
・ポリペプチド薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Novartis、Merck Serono、Ferring Pharmaceuticals、Ipsen PHarma Biotech、Lilly、Asahi Kasei、AstraZeneca、SciClone Pharmaceuticals、Takeda、Roche、Sanofi、）
・ポリペプチド薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Polypeptide Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Polypeptide Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polypeptide Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Polypeptide Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Polypeptide Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis
Merck Serono
Ferring Pharmaceuticals
Ipsen PHarma Biotech
Lilly
Asahi Kasei
AstraZeneca
SciClone Pharmaceuticals
Takeda
Roche
Sanofi

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Injection
Nasal administration
Lung administration
Oral administration
Transdermal administration

Segment by Application
Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug
Urinary System Drug
Metabolic Drug (Insulin and Other Hypoglycemic Agents)

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Polypeptide Drug
1.1 Definition of Polypeptide Drug
1.2 Polypeptide Drug Segment by Type
1.2.1 Global Polypeptide Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Injection
1.2.3 Nasal administration
1.2.4 Lung administration
1.2.5 Oral administration
1.2.6 Transdermal administration
1.3 Polypeptide Drug Segment by Applications
1.3.1 Global Polypeptide Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)
1.3.3 Digestive System Drugs (Gastrointestinal Type)
1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
1.3.5 Gynecologic or Obstetric Drug
1.3.6 Tumor Drug
1.3.7 Urinary System Drug
1.3.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
1.4 Global Polypeptide Drug Overall Market
1.4.1 Global Polypeptide Drug Revenue (2014-2025)
1.4.2 Global Polypeptide Drug Production (2014-2025)
1.4.3 North America Polypeptide Drug Status and Prospect (2014-2025)
1.4.4 Europe Polypeptide Drug Status and Prospect (2014-2025)
1.4.5 China Polypeptide Drug Status and Prospect (2014-2025)
1.4.6 Japan Polypeptide Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Polypeptide Drug Status and Prospect (2014-2025)
1.4.8 India Polypeptide Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Polypeptide Drug
2.3 Manufacturing Process Analysis of Polypeptide Drug
2.4 Industry Chain Structure of Polypeptide Drug

3 Development and Manufacturing Plants Analysis of Polypeptide Drug
3.1 Capacity and Commercial Production Date
3.2 Global Polypeptide Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Polypeptide Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Polypeptide Drug Production and Capacity Analysis
4.2 Polypeptide Drug Revenue Analysis
4.3 Polypeptide Drug Price Analysis
4.4 Market Concentration Degree

5 Polypeptide Drug Regional Market Analysis
5.1 Polypeptide Drug Production by Regions
5.1.1 Global Polypeptide Drug Production by Regions
5.1.2 Global Polypeptide Drug Revenue by Regions
5.2 Polypeptide Drug Consumption by Regions
5.3 North America Polypeptide Drug Market Analysis
5.3.1 North America Polypeptide Drug Production
5.3.2 North America Polypeptide Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Polypeptide Drug Import and Export
5.4 Europe Polypeptide Drug Market Analysis
5.4.1 Europe Polypeptide Drug Production
5.4.2 Europe Polypeptide Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Polypeptide Drug Import and Export
5.5 China Polypeptide Drug Market Analysis
5.5.1 China Polypeptide Drug Production
5.5.2 China Polypeptide Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Polypeptide Drug Import and Export
5.6 Japan Polypeptide Drug Market Analysis
5.6.1 Japan Polypeptide Drug Production
5.6.2 Japan Polypeptide Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Polypeptide Drug Import and Export
5.7 Southeast Asia Polypeptide Drug Market Analysis
5.7.1 Southeast Asia Polypeptide Drug Production
5.7.2 Southeast Asia Polypeptide Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Polypeptide Drug Import and Export
5.8 India Polypeptide Drug Market Analysis
5.8.1 India Polypeptide Drug Production
5.8.2 India Polypeptide Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Polypeptide Drug Import and Export

6 Polypeptide Drug Segment Market Analysis (by Type)
6.1 Global Polypeptide Drug Production by Type
6.2 Global Polypeptide Drug Revenue by Type
6.3 Polypeptide Drug Price by Type

7 Polypeptide Drug Segment Market Analysis (by Application)
7.1 Global Polypeptide Drug Consumption by Application
7.2 Global Polypeptide Drug Consumption Market Share by Application (2014-2019)

8 Polypeptide Drug Major Manufacturers Analysis
8.1 Novartis
8.1.1 Novartis Polypeptide Drug Production Sites and Area Served
8.1.2 Novartis Product Introduction, Application and Specification
8.1.3 Novartis Polypeptide Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Merck Serono
8.2.1 Merck Serono Polypeptide Drug Production Sites and Area Served
8.2.2 Merck Serono Product Introduction, Application and Specification
8.2.3 Merck Serono Polypeptide Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Ferring Pharmaceuticals
8.3.1 Ferring Pharmaceuticals Polypeptide Drug Production Sites and Area Served
8.3.2 Ferring Pharmaceuticals Product Introduction, Application and Specification
8.3.3 Ferring Pharmaceuticals Polypeptide Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Ipsen PHarma Biotech
8.4.1 Ipsen PHarma Biotech Polypeptide Drug Production Sites and Area Served
8.4.2 Ipsen PHarma Biotech Product Introduction, Application and Specification
8.4.3 Ipsen PHarma Biotech Polypeptide Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Lilly
8.5.1 Lilly Polypeptide Drug Production Sites and Area Served
8.5.2 Lilly Product Introduction, Application and Specification
8.5.3 Lilly Polypeptide Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Asahi Kasei
8.6.1 Asahi Kasei Polypeptide Drug Production Sites and Area Served
8.6.2 Asahi Kasei Product Introduction, Application and Specification
8.6.3 Asahi Kasei Polypeptide Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 AstraZeneca
8.7.1 AstraZeneca Polypeptide Drug Production Sites and Area Served
8.7.2 AstraZeneca Product Introduction, Application and Specification
8.7.3 AstraZeneca Polypeptide Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 SciClone Pharmaceuticals
8.8.1 SciClone Pharmaceuticals Polypeptide Drug Production Sites and Area Served
8.8.2 SciClone Pharmaceuticals Product Introduction, Application and Specification
8.8.3 SciClone Pharmaceuticals Polypeptide Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Takeda
8.9.1 Takeda Polypeptide Drug Production Sites and Area Served
8.9.2 Takeda Product Introduction, Application and Specification
8.9.3 Takeda Polypeptide Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Roche
8.10.1 Roche Polypeptide Drug Production Sites and Area Served
8.10.2 Roche Product Introduction, Application and Specification
8.10.3 Roche Polypeptide Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Sanofi

9 Development Trend of Analysis of Polypeptide Drug Market
9.1 Global Polypeptide Drug Market Trend Analysis
9.1.1 Global Polypeptide Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Polypeptide Drug Regional Market Trend
9.2.1 North America Polypeptide Drug Forecast 2019-2025
9.2.2 Europe Polypeptide Drug Forecast 2019-2025
9.2.3 China Polypeptide Drug Forecast 2019-2025
9.2.4 Japan Polypeptide Drug Forecast 2019-2025
9.2.5 Southeast Asia Polypeptide Drug Forecast 2019-2025
9.2.6 India Polypeptide Drug Forecast 2019-2025
9.3 Polypeptide Drug Market Trend (Product Type)
9.4 Polypeptide Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Polypeptide Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Polypeptide Drug
Table Global Polypeptide Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Polypeptide Drug Production Market Share by Types in 2018
Figure Injection Product Picture
Figure Nasal administration Product Picture
Figure Lung administration Product Picture
Figure Oral administration Product Picture
Figure Transdermal administration Product Picture
Table Global Polypeptide Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Polypeptide Drug Consumption Market Share by Applications in 2018
Figure Immunity Regulating Medicine (Allergy Infection and Immune)
Figure Digestive System Drugs (Gastrointestinal Type)
Figure Bone and Connective Tissue Types (Thyroid hormones Drug)
Figure Gynecologic or Obstetric Drug
Figure Tumor Drug
Figure Urinary System Drug
Figure Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Figure Global Polypeptide Drug Revenue (Million USD) (2014-2025)
Figure Global Polypeptide Drug Production (K Pcs) (2014-2025)
Figure North America Polypeptide Drug Market Size (Million USD) (2014-2025)
Figure Europe Polypeptide Drug Market Size (Million USD) (2014-2025)
Figure China Polypeptide Drug Market Size (Million USD) (2014-2025)
Figure Japan Polypeptide Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Polypeptide Drug Market Size (Million USD) (2014-2025)
Figure India Polypeptide Drug Market Size (Million USD) (2014-2025)
Table Polypeptide Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Polypeptide Drug in 2018
Figure Manufacturing Process Analysis of Polypeptide Drug
Figure Industry Chain Structure of Polypeptide Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Polypeptide Drug Manufacturing Plants Distribution
Table Polypeptide Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Polypeptide Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Polypeptide Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Polypeptide Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Polypeptide Drug Production Share by Manufacturers in 2018
Table Polypeptide Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Polypeptide Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Polypeptide Drug Revenue Share by Manufacturers in 2018
Table Polypeptide Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Polypeptide Drug Production by Regions 2014-2019 (K Pcs)
Table Global Polypeptide Drug Production Market Share by Regions 2014-2019
Figure Global Polypeptide Drug Production Market Share by Regions in 2018
Table Global Polypeptide Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Polypeptide Drug Revenue Market Share by Regions 2014-2019
Figure Global Polypeptide Drug Revenue Market Share by Regions in 2018
Table Global Polypeptide Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Polypeptide Drug Consumption Market Share by Regions 2014-2019
Figure North America Polypeptide Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Polypeptide Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Polypeptide Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Polypeptide Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Polypeptide Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Polypeptide Drug Production, Consumption Import and Export (K Pcs)
Figure China Polypeptide Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Polypeptide Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Polypeptide Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Polypeptide Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Polypeptide Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Polypeptide Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Polypeptide Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Polypeptide Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Polypeptide Drug Production, Consumption Import and Export (K Pcs)
Figure India Polypeptide Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Polypeptide Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Polypeptide Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Polypeptide Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Polypeptide Drug Market Share by Application (2014-2019)
Table Novartis Polypeptide Drug Production Sites and Area Served
Table Novartis Polypeptide Drug Product Introduction, Application and Specification
Table Novartis Polypeptide Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis Polypeptide Drug Production Growth Rate (2014-2019)
Table Novartis Polypeptide Drug Production Market Share (2014-2019)
Figure Novartis Polypeptide Drug Revenue Market Share (2014-2019)
Table Novartis Polypeptide Drug Main Business and Markets Served
Table Merck Serono Polypeptide Drug Production Sites and Area Served
Table Merck Serono Polypeptide Drug Product Introduction, Application and Specification
Table Merck Serono Polypeptide Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck Serono Polypeptide Drug Production Growth Rate (2014-2019)
Table Merck Serono Polypeptide Drug Production Market Share (2014-2019)
Figure Merck Serono Polypeptide Drug Revenue Market Share (2014-2019)
Table Merck Serono Polypeptide Drug Main Business and Markets Served
Table Ferring Pharmaceuticals Polypeptide Drug Production Sites and Area Served
Table Ferring Pharmaceuticals Polypeptide Drug Product Introduction, Application and Specification
Table Ferring Pharmaceuticals Polypeptide Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ferring Pharmaceuticals Polypeptide Drug Production Growth Rate (2014-2019)
Table Ferring Pharmaceuticals Polypeptide Drug Production Market Share (2014-2019)
Figure Ferring Pharmaceuticals Polypeptide Drug Revenue Market Share (2014-2019)
Table Ferring Pharmaceuticals Polypeptide Drug Main Business and Markets Served
Table Ipsen PHarma Biotech Polypeptide Drug Production Sites and Area Served
Table Ipsen PHarma Biotech Polypeptide Drug Product Introduction, Application and Specification
Table Ipsen PHarma Biotech Polypeptide Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ipsen PHarma Biotech Polypeptide Drug Production Growth Rate (2014-2019)
Table Ipsen PHarma Biotech Polypeptide Drug Production Market Share (2014-2019)
Figure Ipsen PHarma Biotech Polypeptide Drug Revenue Market Share (2014-2019)
Table Ipsen PHarma Biotech Polypeptide Drug Main Business and Markets Served
Table Lilly Polypeptide Drug Production Sites and Area Served
Table Lilly Polypeptide Drug Product Introduction, Application and Specification
Table Lilly Polypeptide Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Lilly Polypeptide Drug Production Growth Rate (2014-2019)
Table Lilly Polypeptide Drug Production Market Share (2014-2019)
Figure Lilly Polypeptide Drug Revenue Market Share (2014-2019)
Table Lilly Polypeptide Drug Main Business and Markets Served
Table Asahi Kasei Polypeptide Drug Production Sites and Area Served
Table Asahi Kasei Polypeptide Drug Product Introduction, Application and Specification
Table Asahi Kasei Polypeptide Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Asahi Kasei Polypeptide Drug Production Growth Rate (2014-2019)
Table Asahi Kasei Polypeptide Drug Production Market Share (2014-2019)
Figure Asahi Kasei Polypeptide Drug Revenue Market Share (2014-2019)
Table Asahi Kasei Polypeptide Drug Main Business and Markets Served
Table AstraZeneca Polypeptide Drug Production Sites and Area Served
Table AstraZeneca Polypeptide Drug Product Introduction, Application and Specification
Table AstraZeneca Polypeptide Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AstraZeneca Polypeptide Drug Production Growth Rate (2014-2019)
Table AstraZeneca Polypeptide Drug Production Market Share (2014-2019)
Figure AstraZeneca Polypeptide Drug Revenue Market Share (2014-2019)
Table AstraZeneca Polypeptide Drug Main Business and Markets Served
Table SciClone Pharmaceuticals Polypeptide Drug Production Sites and Area Served
Table SciClone Pharmaceuticals Polypeptide Drug Product Introduction, Application and Specification
Table SciClone Pharmaceuticals Polypeptide Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table SciClone Pharmaceuticals Polypeptide Drug Production Growth Rate (2014-2019)
Table SciClone Pharmaceuticals Polypeptide Drug Production Market Share (2014-2019)
Figure SciClone Pharmaceuticals Polypeptide Drug Revenue Market Share (2014-2019)
Table SciClone Pharmaceuticals Polypeptide Drug Main Business and Markets Served
Table Takeda Polypeptide Drug Production Sites and Area Served
Table Takeda Polypeptide Drug Product Introduction, Application and Specification
Table Takeda Polypeptide Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Takeda Polypeptide Drug Production Growth Rate (2014-2019)
Table Takeda Polypeptide Drug Production Market Share (2014-2019)
Figure Takeda Polypeptide Drug Revenue Market Share (2014-2019)
Table Takeda Polypeptide Drug Main Business and Markets Served
Table Roche Polypeptide Drug Production Sites and Area Served
Table Roche Polypeptide Drug Product Introduction, Application and Specification
Table Roche Polypeptide Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Roche Polypeptide Drug Production Growth Rate (2014-2019)
Table Roche Polypeptide Drug Production Market Share (2014-2019)
Figure Roche Polypeptide Drug Revenue Market Share (2014-2019)
Table Roche Polypeptide Drug Main Business and Markets Served
Table Sanofi Polypeptide Drug Production Sites and Area Served
Figure Global Polypeptide Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Polypeptide Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Polypeptide Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Polypeptide Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Polypeptide Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Polypeptide Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Polypeptide Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Polypeptide Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Polypeptide Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Polypeptide Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Polypeptide Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Polypeptide Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Polypeptide Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Polypeptide Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Polypeptide Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Polypeptide Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Polypeptide Drug by Application (2019-2025)
Table Polypeptide Drug Distributors List
Table Polypeptide Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Novartis、Merck Serono、Ferring Pharmaceuticals、Ipsen PHarma Biotech、Lilly、Asahi Kasei、AstraZeneca、SciClone Pharmaceuticals、Takeda、Roche、Sanofi、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のポリペプチド薬市場(Global Polypeptide Drug Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp